Skip to main content
Molecular and Cellular Pediatrics
Molecular and Cellular Pediatrics Cover Image
Help us understand how you use our websites. Take part in our 30 minute study now.
Download PDF

Volume 2 Supplement 1

Abstracts of the 51st Workshop for Pediatric Research

Nexilin mutations are associated with left ventricular noncompaction cardiomyopathy

Molecular and Cellular Pediatrics volume 2, Article number: A7 (2015) Cite this article

Introduction

Left Ventricular Noncompaction Cardiomyopathy (LVNC) is a very rare congenital heart disease. LVNC is a form of cardiomyopathy in which the fetal myocardium fails to "compact" during cardiac development and it may be associated with impairment of LV function and LV dilatation. Mutations in several sarcomere genes have been described in LVNC. Nexilin, encoded by NEXN, is a cardiac Z-disc protein that stabilizes the sarcomere. We evaluated nexilin as a disease gene for LVNC.

Methods

Ninety-two LVNC patients and 254 controls were screened and NEXN was sequenced by Sanger sequencing.

Results

We found a missense mutation (c.1408 G>C, p.Glu470Gln) in one patient and a nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations were detected in the healthy controls. In addition, we identified one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heterozygous in three LVNC patients. This polymorphism was also found in 78 controls (homozygous in 12 and heterozygous in 64 controls).

Conclusion

Mutations in genes encoding Z-disc proteins such as nexilin have been shown to cause different forms of cardiomyopathy. Therefore, the two mutations we identified in NEXN may further increase our knowledge of Z-disc genes in the pathogenesis of LVNC. To establish the disease causality, it is necessary to investigate the effect of the mutations on protein function in further in vitro studies.

Author information

Affiliations

  1. Dept. of Pediatric Cardiology, ECRC, University Medicine-Charité, Berlin, Germany

    E Pardun, K Wenzel, F Berger & S Klaassen

  2. Dept. of Congenital Heart Disease, University Clinic, Kiel, Germany

    E Pardun & H-H Kramer

  3. University of Calgary, Calgary, Alberta, Canada

    B Gerull

Authors
  1. E Pardun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Wenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H-H Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Gerull
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Klaassen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Pardun.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pardun, E., Wenzel, K., Kramer, H. et al. Nexilin mutations are associated with left ventricular noncompaction cardiomyopathy. Mol Cell Pediatr 2, A7 (2015). https://doi.org/10.1186/2194-7791-2-S1-A7

Download citation

Keywords

  • Nucleotide
  • Heart Disease
  • Cardiomyopathy
  • Congenital Heart Disease
  • Congenital Heart